LENZ will obtain up to $125m in payments from Lotus, including upfront, regulatory, and commercial milestones.

Presbyopia is caused by a stiffening in the lens of the eye that develops in people after the age of 40, and affects an estimated 128 million people in the US. AbbVie is recommending Vuity ...

Do you squint to read print that was always clear before? You may have blurry near-sighted vision or something called presbyopia. It’s pretty common among adults over 40. In fact, according to a ...

LENZ Therapeutics (formerly Presbyopia Therapies) is working on eyedrops containing aceclidine – thought to act like pilocarpine as a miotic agent, reducing eye pressure – showed improvements ...

Visakhapatnam: A 15-year follow-up of 5,395 participants from the erstwhile combined Andhra Pradesh (encompassing both ...

LOS ANGELES — Patients implanted with a presbyopia-correcting IOL reported high satisfaction after surgery and preserved visual acuity in low light environments, according to a study.

Lotus aims to leverage its commercial strength and experience to bring LNZ100 to this region, which has over 100 million individuals affected by presbyopia. LENZ announced in October 2024 that the ...

The World Health Organization (WHO) has partnered with the Universal Postal Union (UPU) to expand access to eye care using ...

Research and Development (R&D) Expenses: R&D expenses decreased to $5.8 million for the three months ended March 31, 2025, ...

Most patients were not bothered by most visual disturbances. LOS ANGELES — Patients implanted with a presbyopia-correcting IOL reported high satisfaction after surgery and preserved visual ...

“Presbyopia affects over 2.1 billion people globally, representing one of the most common, yet underserved, conditions in vision care” emphasized Dr. Hipsley. Ace Vision Group’s patented LSM ...